This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novozymes A/s. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Sune Sauer Lobedanz: Innovator in Xylanase Variants
Introduction
Sune Sauer Lobedanz is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of xylanase variants. His work has implications for various industrial applications, showcasing the importance of innovation in enzyme technology.
Latest Patents
Sune holds a patent for "GH8 xylanase variants." This invention relates to isolated polypeptides that exhibit xylanase activity, as well as isolated polynucleotides that encode these polypeptides. The patent also encompasses nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides, along with methods for producing and utilizing the polypeptides. He has 1 patent to his name.
Career Highlights
Sune is currently employed at Novozymes A/S, a leading company in the field of enzyme production and biotechnology. His role at Novozymes allows him to apply his expertise in enzyme technology to develop innovative solutions for various industries.
Collaborations
Throughout his career, Sune has collaborated with esteemed colleagues such as Henrik Lundkvist and Lars Beier. These partnerships have contributed to the advancement of research and development in enzyme technology.
Conclusion
Sune Sauer Lobedanz is a prominent figure in the field of biotechnology, particularly known for his work on xylanase variants. His contributions through patents and collaborations highlight the significance of innovation in advancing enzyme technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile